Precision Oncology in Early-Stage Lung Cancer, With Adjuvant EGFR-Targeted Therapy Leading the Way

Precision Oncology in Early-Stage Lung Cancer, With Adjuvant EGFR-Targeted Therapy Leading the Way

Co-Chairs, Boris Sepesi, MD, and Tina Cascone, MD, PhD, discuss NSCLC in this CME/MOC activity titled “Bringing Precision Oncology to Early-Stage Lung Cancer, With Adjuvant EGFR-Targeted Therapy Leading the Way: What Thoracic Surgeons Need to Know and Do.” For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/FYQ865. CME/MOC credit will be available until February 27, 2023.